| Trial ID: | L4381 |
| Source ID: | NCT00328536
|
| Associated Drug: |
Omacor
|
| Title: |
Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Atherosclerosis|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Omacor
|
| Outcome Measures: |
Primary: Postprandial (2, 4 and 6 hours) flow-mediated vasodilation after a 6-week treatment with Omacor | Secondary: Baseline flow-mediated vasodilation after a 6-week treatment with Omacor
|
| Sponsor/Collaborators: |
Sponsor: Ruhr University of Bochum | Collaborators: Heart and Diabetes Center North-Rhine Westfalia|Solvay Pharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
2008-11
|
| Results First Posted: |
|
| Last Update Posted: |
2009-05-08
|
| Locations: |
Heart- and Diabetes Centre NRW, Diabetes Clinic, Bad Oeynhausen, NRW, 32545, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00328536
|
